Insider / SEMTECH CORP
Burvill Martin
Director at SEMTECH CORP
- Company
- SEMTECH CORP
- Ticker
- SMTC
- First filing on record
- April 13, 2026
- Latest trade on record
- June 4, 2026
- SEC filings
- EDGAR ↗
Burvill Martin, Director at SEMTECH CORP, has disclosed 2 transactions in SMTC since April 13, 2026: 0 purchases (0 open-market buys) and 1 sale, worth about $222K at the reported prices. The latest was filed June 5, 2026, 1 day after the trade.
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
In the last 12 months Burvill Martin made no purchases and 1 sale worth $222K, plus 1 other transaction. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Burvill Martin has traded 1 stock on record; the largest by dollars is SMTC.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
0 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 1 | 1,180 | — |
| S | Open-market sale | 1 | 2,500 | $222K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 2 | 0 | 1 · $222K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| SMTC | Other A | June 4, 2026 | June 5, 2026 | 1d | 1,180 | — | — | derivative | Form 4 ↗ | |
| SMTC | Sell S | April 9, 2026 | April 13, 2026 | 4d | 2,500 | $89 | $222K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| June 5, 2026 | Form 4 | 0001826529-26-000006 | 1 | published | EDGAR ↗ |
| April 13, 2026 | Form 4 | 0001826529-26-000003 | 1 | published | EDGAR ↗ |
Other insiders at SEMTECH CORP
- Lin Mark EVP and CFO 50 rows
- HOU HONG Q President and CEO 40 rows
- Silberstein Asaf EVP and COO 39 rows
- WILSON JOHN MICHAEL Chief Quality Officer and CTO 25 rows
- Green Jason Elliot EVP and CCO 17 rows
- Walsh Paul V Jr Director 16 rows
- Fischer Gregory Michael Director 6 rows
- Cardenuto Rodolpho C Director 4 rows
- Gillai Saar Director 4 rows
- Li Ye Jane Director 4 rows
Everyone on file, with contracts and lobbying under the company's name: SEMTECH CORP.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 2 | April 13, 2026 | June 5, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.